GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Intelligent Medicine Acquisition Corp (NAS:IQMDU) » Definitions » Shares Outstanding (EOP)

IQMDU (Intelligent Medicine Acquisition) Shares Outstanding (EOP) : 25.88 Mil (As of Dec. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Intelligent Medicine Acquisition Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Intelligent Medicine Acquisition's shares outstanding for the quarter that ended in Dec. 2022 was 25.88 Mil.

Intelligent Medicine Acquisition's quarterly shares outstanding stayed the same from Sep. 2022 (25.88 Mil) to Dec. 2022 (25.88 Mil).

Intelligent Medicine Acquisition's annual shares outstanding stayed the same from Dec. 2021 (0.00 Mil) to Dec. 2022 (0.00 Mil).


Intelligent Medicine Acquisition Shares Outstanding (EOP) Historical Data

The historical data trend for Intelligent Medicine Acquisition's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelligent Medicine Acquisition Shares Outstanding (EOP) Chart

Intelligent Medicine Acquisition Annual Data
Trend Dec21 Dec22
Shares Outstanding (EOP)
- -

Intelligent Medicine Acquisition Quarterly Data
Feb21 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22
Shares Outstanding (EOP) Get a 7-Day Free Trial 25.88 25.88 25.88 25.88 25.88

Competitive Comparison of Intelligent Medicine Acquisition's Shares Outstanding (EOP)

For the Shell Companies subindustry, Intelligent Medicine Acquisition's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intelligent Medicine Acquisition's Shares Outstanding (EOP) Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Intelligent Medicine Acquisition's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Intelligent Medicine Acquisition's Shares Outstanding (EOP) falls into.



Intelligent Medicine Acquisition Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Intelligent Medicine Acquisition  (NAS:IQMDU) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Intelligent Medicine Acquisition Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Intelligent Medicine Acquisition's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Intelligent Medicine Acquisition Business Description

Traded in Other Exchanges
N/A
Address
9001 Burdette Road, Bethesda, MD, USA, 20817
Intelligent Medicine Acquisition Corp is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
Executives
Goldman Sachs & Co. Llc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Saba Capital Management, L.p. 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Joseph L Schocken director 2800 UNION SQUARE, 600 UNIVERSITY STREET, SEATTLE WA 98101
Kavita Patel director C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Jack Hidary director 3 PARK AVENUE, NEW YORK NY 10016
Gregory C Simon director, officer: CEO and CFO 9001 BURDETTE RD., BETHESDA MD 20817
Patience Marime-ball director 9001 BURDETTE RD., BETHESDA MD 20817
Intelligent Medicine Sponsor Llc 10 percent owner 9001 BURDETTE ROAD, BETHESDA MD 20817